-
Value proposition
We have merged with Bristol Myers Squibb creating a leading biopharma company, ideally positioned to discover, develop and deliver innovative medicines for patients fighting serious diseases. Visit www.bms.com to continue to learn more about our work to produce the next generation of medicines to treat cancer and other serious diseases.
For more information on the acquisition, see our press release at: http://bit.ly/3UbQcnl
Hematology, Oncology, Inflammation, Immunology, Cancer, R&D, Innovation, Immunooncology, biopharma, Epigenetics, Protein Homeostasis, Translation Medicine, and Orphan diseases
-
Global Biopharmaceutical Company - Bristol Myers Squibb
Global Biopharmaceutical Company - Bristol Myers Squibb
https://www.bms.com/
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
|
imec.xpand
Venture Capital and Private Equity Principals (Auto) |
Other
31 Mar 2025 |
|
|
|
Cellarity
biotech, deeptech, Biotechnology Research (Auto) |
Other
31 Dec 2024 |
|
|
|
Les Echos Etudes
constructiontech, healthtech, martech, transporttech, agritech, Market Research (Auto) |
Other
28 Jun 2024 |
|
|
|
CellProthera SAS
biotech, deeptech, Biotechnology Research (Auto) |
Other
7 Mar 2024 |
|
|
|
JEITO
Venture Capital and Private Equity Principals (Auto) |
Other
5 Jan 2024 |
|
|
|
Airfinity Ltd
healthtech, biotech, deeptech, Information Services (Auto) |
Other
8 Aug 2023 |
|
|
|
Center for Genomic Interpretation
biotech, deeptech, Hospitals and Health Care (Auto) |
Other
31 Jul 2023 |
|
|
|
BioPharma Asia Magazine
Book and Periodical Publishing (Auto) |
Other
31 Jul 2022 |
|
|
|
HealthBeacon
healthtech, Hospitals and Health Care (Auto) |
Other
14 Oct 2022 |
|
|
|
libheros
healthtech, Home Health Care Services (Auto) |
Other
29 Dec 2022 |
|
|